Morgan Stanley analyst Vincent Andrews lowered the firm’s price target on Albemarle (ALB) to $68 from $73 and keeps an Underweight rating on the shares after updating estimates post Q4 reporting, citing lower 2026 and later EBITDA forecasts.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALB: